Tuesday’s packed full of big breaking news. Right now several key sectors are seeing premarket activity. With a new focus on biotech and defense, now could be the time to start taking notice:
Laurentian Bank Securities Inc. Initiates Analyst Coverage of Liberty Defense and Technology Transfer Award
VANCOUVER , Sept. 10, 2019 /CNW/ – Liberty Defense Holdings Ltd. (“Liberty” or the “Company”) (TSXV: SCAN; FRANKFURT : LD2; OTCQB:LDDFF), a leading concealed weapons detection solutions company, is pleased to announce that Laurentian Bank Securities Inc. has initiated coverage of the Company, that MIT has received the FLC Award for its transfer of the technology behind HEXWAVE, and the Company’s recent presentation to the National Legislative Service and Security Association (NLSSA).
Tiziana Reports Phase 1 Clinical Data Demonstrating Nasal Treatment with Foralumab was Well-tolerated and Produced Positive Trend in Biomarkers of Immunomodulation and Anti-inflammation in Healthy Volunteers
Tiziana Life Sciences plc (TLSA) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for inflammatory diseases and cancers, is pleased to report Phase 1 clinical data demonstrating that nasally administered Foralumab, a fully human anti-CD3 monoclonal antibody (mAb), was well-tolerated at all doses. Importantly, the treatment showed significant positive effects on the biomarkers for activation of mucosal immunity, which is capable of inducing site-targeted immunomodulation to elicit anti-inflammatory effects.